Today, one in five sponsors uses social media to engage, recruit, and retain subjects for clinical trials.
And why not? Clearly, social media is increasingly where your prospective study subjects are going to be found.
This report is designed to help unsure clinical trial recruiters put aside their concerns and go ahead with social media recruiting of trial subjects.
And if you're already using social media, it's an opportunity to hear how other organizations are overcoming challenges and employing social media for increasingly successful recruitment.
With the report, you'll also get access to relevant survey results and pick up social media tips and techniques being employed all around the country, including:
The importance of social media sharing and how it can supercharge your recruiting efforts
Results of a 1000-patient survey that reveal clinical trial subjects' online behaviors
The most effective social media techniques for reaching study subjects
How to avoid the 'rookie mistakes' that drug companies make when they first use social media to recruit
Where patients search for clinical trial information online
How to review your social media efforts — and make them more effective
What patients think about clinical trial sponsors and social media
How to tell if you’re overspending on your social media campaigns
There's absolutely no doubt: The patients you need for your clinical studies are online, waiting to hear from you. Let Using Social Media in Clinical Trial Recruitment show you how to reach them successfully.
Save money with a license agreement allowing significant numbers of users access to an electronic version of this book. For multi-user access to multiple titles, FDAnews offers the FDAnews Online Library — a personalized collection of FDAnews publications that is fully searchable. Contact Customer Service for a quote or more information.
Not satisfied with your publication? For the PDF version, you must notify FDAnews within 24 hours of receipt of purchase and we will refund 100 percent of your purchase price.